Drugmaker Sanofi SA will buy Amunix Pharmaceuticals Inc for an upfront payment of about $1 billion, marking the latest acquisition by the French drugmaker in the U.S. biotech sphere as Sanofi aims. | December 21, 2021
By Cristina Roca Sanofi SA and GlaxoSmithKline PLC said Wednesday that a single booster dose of their Covid-19 vaccine candidate delivered consistently strong immune responses. . | December 15, 2021
Vaccines Investor Event: Sanofi reiterates confidence in strong growth outlook and showcases pipeline of innovative vaccine candidates Sanofi confirms Vaccines mid-term. | December 1, 2021
Already positive, the research from JP Morgan and its analyst Richard Vosser still consider the stock as a Buy opportunity. The target price remains set at EUR 105. | December 1, 2021